China Regenerative Medicine International Limited announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was HKD 13.001 million compared to HKD 9.222 million a year ago. Net loss was HKD 22.178 million compared to HKD 56.293 million a year ago. Basic loss per share was HKD 0.02522 compared to HKD 0.06402 a year ago. For the nine months, sales was HKD 35.362 million compared to HKD 74.752 million a year ago. Net loss was HKD 82.931 million compared to HKD 244.569 million a year ago. Basic loss per share was HKD 0.09432 compared to HKD 0.27814 a year ago.